Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling


Posted: 2021-10-21 19:00:00
Purpose: We developed an accessible method for labeling small extracellular vesicles (sEVs) without disrupting endogenous ligands. Using labeled sEVs administered to conscious rats, we developed a multiple compartment pharmacokinetic model to identify potential differences in the disposition of sEVs from three different cell types. Methods: Crude sEVs were labeled with a non-homologous oligonucleotide and isolated from cell culture media using a commercial reagent. Jugular vein catheters were used to introduce EVs to conscious rats (n = 30) and to collect blood samples. Digital PCR was leveraged to allow for quantification over a wide dynamic range. Non-linear mixed effects analysis with first order conditional estimation - extended least squares (FOCE ELS) was used to estimate population-level parameters with associated intra-animal variability. Results: 86.5% ± 1.5% (mean ± S.E.) of EV particles were in the 45-195 nm size range and demonstrated protein and lipid markers of endosomal origin. Incorporated oligonucleotide was stable in blood and detectable over five half-lives. Data were best described by a three-compartment model with one elimination from the central compartment. We performed an observation-based simulated posterior predictive evaluation with prediction-corrected visual predictive check. Covariate and bootstrap analyses identified cell type having an influence on peripheral volumes (V2 and V3) and clearance (Cl3). Conclusions: Our method relies upon established laboratory techniques, can be tailored to a variety of biological questions regarding the pharmacokinetic disposition of extracellular vesicles, and will provide a complementary approach for the of study EV ligand-receptor interactions in the context of EV uptake and targeted therapeutics. Keywords: droplet digital PCR (ddPCR); exosomes; extracellular vesicles; pharmacokinetics; tracer miRNA.

参考サイト PubMed: exsome



バイオクイックニュース日本語版:エクソソーム特集

バイオクイックニュース日本語版
4月 14, 2021 バイオアソシエイツ

悪性黒色腫患者のエクソソームに含まれる癌幹細胞バイオマーカーにより診断の早期化と予後改善の可能性

悪性黒色腫患者の癌幹細胞(cancer stem cells :CSC)から放出された エクソソーム は、分化した悪性黒色腫細胞からのエクソソームとは異なる分子組成を持つことが新しい研究で明らかになった。これらの異なる分子は、血液中のエクソソームでも検出可能であり、悪性黒色腫患者では健常者と比べて違いがあることがわかった。このことから、これらの分子は、悪性黒色腫の診断や予後を判定するためのバイオマーカーとして適していると考えられるという。本研究成果は、Molecular…

ゲスト 723人 と メンバー 6人 がオンラインです